Log in or Sign up for Free to view tailored content for your specialty!
Psychiatry News
VIDEO: Pharmaceutical advancements may increase awareness of Huntington's disease
Kathryn P. L. Moore, MD, MSc, assistant professor of neurology at Duke University School of Medicine, emphasizes the need for Huntington's disease awareness among providers and the general public.
VIDEO: Disease-modifying medications may help address unmet needs in Huntington’s disease
Kathryn P. L. Moore, MD, MSc, assistant professor of neurology at Duke University School of Medicine, discusses the unmet needs among patients with Huntington's disease and the clinicians who treat them.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: AAP warns about climate change’s impact on child health
An updated AAP policy statement outlines the impact of climate change on children’s health and offers related recommendations for the medical and government sectors.
A ‘low-judgment zone’ needed to manage the psychosocial needs of breast cancer survivors
A woman in her late 50s is currently receiving treatment for her second bout of breast cancer. She is thought to be in remission, but Neelam Desai, MD, worries about more than just the disease.
Opioid use increases risk for serious falls among all ages, researchers find
Opioid use was associated with an increased risk for serious falls among all age groups, especially during the first 28 days after initiation, according to a study published in JAMA Internal Medicine.
Rule streamlining prior authorization is a step forward for primary care, 'but not a leap'
The new CMS rule aiming to streamline prior authorization signals a major step forward for primary care, but the process could still use some improvement, according to experts.
Statins may lower risk for any dementia among adults with heart failure
Researchers reported that a population-based study shows statin use among older adults with heart failure was associated with a 20% lower risk for all-cause dementia, including a 28% reduction in risk for developing Alzheimer’s disease.
Phase 3 study of agitation drug fails to achieve primary efficacy endpoint
Otsuka has announced that a phase 3 clinical trial of AVP-786, a combination therapy to treat agitation associated with dementia due to Alzheimer’s disease, failed to achieve its primary endpoints.
When all else fails: Treating hyperhidrosis with endoscopic thoracic sympathectomy
It was just another day at school when sophomore Cole Villaflor and his classmates were asked to write on-demand essays in class. As he approached this seemingly easy assignment, his hands began to sweat, dampening the page.
VIDEO: Tardive dyskinesia social stigma impacts patients' mental health
Adam Margolius, MD, neurology specialist at Cleveland Clinic discusses the impact that tardive dyskinesia on a patient's daily life and mental health.